Forward P/S Multiple: Stereotaxis (STXS)
Is the Stereotaxis, Inc. (STXS) business shielded from external political shocks? Global deliveries of cardiac robots hold humanitarian status, while cash flow stability is ensured by the sale of consumables. The projected P/S of the business on the GURU.Markets chart confirms the value of high-precision magnetic systems, with the 2.70 value capturing the metric level and underscoring technological leadership in minimally invasive cardiology.
Summary analytical data breakdowns for Stereotaxis Corporation (STXS)
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- issuer book value statistics:
- debt and liquidity data:
Total Debt to Capital Stereotaxis, Inc.|STXS - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Stereotaxis, Inc.|STXS - Company Aggregate Debts|Debt to Book Capitalization Ratio Stereotaxis Corporation|STXS - Company Long-Term Debt|Company Current Liabilities Stereotaxis|Quick Ratio stereotaxis.com
- financial results and valuation multiples details:
STXS - Company Net Income|Expected Profit Stereotaxis, Inc.|STXS - Market Cap to Net Income Ratio|Projected Price to Earnings Stereotaxis Corp|STXS - PEG Multiple|EV/EBITDA Multiple Stereotaxis Corporation|STXS - Operating income before deduction of amortization|Earnings per share for the last twelve months Stereotaxis|STXS - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months stereotaxis.com|STXS - Net earnings per share growth this year|Earnings growth forecast for next year Stereotaxis, Inc.
- sales and revenue indicators:
Fundamental company analysis:STXS (Stereotaxis)
Forward P/S determines the market value of an asset relative to projected sales volume, allowing investors to assess the premium paid for expected revenue in real-time. By analyzing the forward P/S trend, one can identify optimal entry points for capital investment in Stereotaxis, Inc. (STXS), whose unique robotic systems for cardiac surgery ensure high surgical precision and fundamental brand stability.
Who Stereotaxis, Inc. competes with
Price-to-Projected Revenue Ratio Boston Scientific Corporation BSX|EW - Forward Price-to-Revenue Multiple|ResMed Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio Insulet Inc.|ZBH: Forward P/S Multiple|Market Cap to Projected Revenue COO|ALGN (Align Technology) - Forward P/S Multiple|Globus Medical Inc (GMED) - Market Cap to Expected Sales Ratio|Forward P/S Multiple TMDX|Forward Price-to-Revenue Multiple Alphatec Corp ATEC|Forward P/S Multiple AORT (Artivion, Inc.)|Forward P/S Multiple enovis.com ENOV|IART - Price-to-Projected Revenue Ratio|ESTA: Price-to-Projected Revenue Ratio|BBNX (Beta Bionics Corp) - Forward Price-to-Revenue Multiple|IRADIMED Inc. - Forward Price to Sales|EMBC (Embecta Corp.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio tandemdiabetes.com TNDM|Price-to-Projected Revenue Ratio Axogen (AXGN)|SI-BONE Inc (SIBN) - Projected Price to Revenue|Orthofix International - Forward Price-to-Revenue Multiple|Forward P/S Multiple Bioventus Global BVS|OrthoPediatrics Inc. - Forward P/S Multiple|Market Cap to Expected Sales Ratio treace.com TMCI|Strata Critical Medical (SRTA) - Price-to-Projected Revenue Ratio|Future Price to Revenue CARL (Carlsmed, Inc.)|Price-to-Projected Revenue Ratio RxSight Corp|Forward Price-to-Revenue Multiple ClearPoint (CLPT)|Forward P/S Multiple STIM|SGHT - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Orchestra BioMed, Inc. OBIO|ANIK: Market Cap to Projected Revenue|NSPR: Forward Price-to-Revenue Multiple|Jin Medical International - Price to Expected Revenue Ratio|vivani.com (VANI) - Price-to-Projected Revenue Ratio|XTNT - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple NMTC|MODD (Modular Med) - Price to Expected Revenue Ratio|Forward P/S Multiple MYO|COCH - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Vivos Therapeutics VVOS|Forward Price to Sales NVNO|SINTX Technologies - Forward P/S Multiple|Market Cap to Future Revenue Ratio Tenon Medical Inc.|ReWalk Robotics Ltd (LFWD) - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Autonomix Medical (AMIX)|Forward Price-to-Revenue Multiple IVF|BBLG (bonebiologics.com) - Price to Expected Revenue Ratio|Forward P/S Multiple AXNX|Forward P/S Multiple BIOLASE Inc. (BIOL)|Dynatronics - Forward Price-to-Revenue Multiple|FNA: Market Cap to Projected Revenue|INVO Bio - Forward P/S Multiple
